Rhumbline Advisers Retractable Technologies Inc Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.39 - $4.69 $52,111 - $72,094	-15,372 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.3 - $7.26 $9,589 - $16,189	2,230 Added 16.97%	15,372 $73,000
Q4 2021 Feb 10, 2022	SELL	$6.74 - $10.69 $2,156 - $3,420	-320 Reduced 2.38%	13,142 $91,000
Q3 2021 Nov 12, 2021	BUY	$10.3 - $13.45 $8,003 - $10,450	777 Added 6.13%	13,462 $148,000
Q2 2021 Aug 05, 2021	BUY	$8.84 - $12.46 $6,904 - $9,731	781 Added 6.56%	12,685 $147,000
Q1 2021 May 06, 2021	SELL	$11.15 - $21.5 $2,453 - $4,730	-220 Reduced 1.81%	11,904 $153,000
Q4 2020 Feb 10, 2021	BUY	$6.7 - $15.02 $8,080 - $18,114	1,206 Added 11.05%	12,124 $130,000
Q3 2020 Nov 12, 2020	SELL	$5.42 - $13.1 $9,457 - $22,859	-1,745 Reduced 13.78%	10,918 $73,000
Q2 2020 Aug 13, 2020	BUY	$1.25 - $7.38 $15,828 - $93,452	12,663 New	12,663 $89,000

2.34M

2.7K

100

Ticker RVP
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 32,937,200
Market Cap $27.3M
Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.